{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:55:41Z","timestamp":1768481741396,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA046000"],"award-info":[{"award-number":["R21DA046000"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jsat.2022.108873","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T05:44:52Z","timestamp":1662702292000},"page":"108873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Opioid relapse and MOUD outcomes following civil commitment for opioid use"],"prefix":"10.1016","volume":"142","author":[{"given":"Jumi","family":"Hayaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley","family":"Cinq-Mars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul P.","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2022.108873_bb0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jsat.2020.01.005","article-title":"Treatment barriers among individuals with co-occurring substance use and mental health problems: Examining gender differences","volume":"112","author":"Agterberg","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108873_bb0010","article-title":"Opioid-related incident severity and emergency medical service naloxone administration by sex in Massachusetts, 2013\u20132019","author":"Bettano","year":"2021","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2022.108873_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajad.12826","article-title":"Gender differences in mental health and substance use disorders and related healthcare service utilization","volume":"28","author":"Brand","year":"2019","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2022.108873_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/00952990.2017.1320802","article-title":"Treatment of opioid use disorder with ibogaine: Detoxification and drug use outcomes","volume":"44","author":"Brown","year":"2018","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2022.108873_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102722","volume":"79","author":"Carlson","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.jsat.2022.108873_bb1000","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/08897077.2015.1029207","article-title":"Considerations in civil commitment of individuals with substance use disorders","volume":"37","author":"Cavaiola","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2022.108873_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drugalcdep.2018.10.001","article-title":"Civil commitment experiences among opioid users","volume":"193","author":"Christopher","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2022.108873_bb0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamapsychiatry.2019.2845","article-title":"Criminalization of opioid civil commitment","volume":"77","author":"Christopher","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2022.108873_bb0040","first-page":"313","article-title":"Nature and utilization of civil commitment for substance abuse in the United States","volume":"43","author":"Christopher","year":"2015","journal-title":"Journal of the American Academy of Psychiatry and the Law"},{"key":"10.1016\/j.jsat.2022.108873_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2022.108873_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108309","article-title":"Negative affect-associated drug refusal self-efficacy, illicit opioid use, and medication use following short-term inpatient opioid withdrawal management","volume":"126","author":"Hayaki","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108873_bb0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.addbeh.2011.11.025","article-title":"Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances \u2013 Systematic review and meta-analysis","volume":"37","author":"Hjorth\u00f8j","year":"2012","journal-title":"Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.jsat.2022.108873_bb2000","first-page":"374","article-title":"Civil commitment for opioid and other substance use disorders: Does it work?","volume":"69","author":"Jain","year":"2018","journal-title":"Law and Psychiatry"},{"key":"10.1016\/j.jsat.2022.108873_bb0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","article-title":"Co-occurring substance use and mental disorders among adults with opioid use disorder","volume":"197","author":"Jones","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2022.108873_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.copsyc.2018.12.020","article-title":"Comorbidity of opioid-related and anxiety-related symptoms and disorders","volume":"30","author":"Langdon","year":"2019","journal-title":"Current Opinion in Psychology"},{"key":"10.1016\/j.jsat.2022.108873_bb0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/ajad.12893","article-title":"A retrospective 4-year outcome study of veterans admitted to an acute inpatient detoxification unit for opioid use disorder","volume":"28","author":"Li","year":"2019","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2022.108873_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm7015a1","article-title":"State-level economic costs of opioid use disorder and fatal opioid overdose \u2013 United States, 2017","volume":"70","author":"Luo","year":"2021","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2022.108873_bb0085","series-title":"Data brief: Opioid-related overdose deaths among Massachusetts residents","year":"2021"},{"key":"10.1016\/j.jsat.2022.108873_bb0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00005053-199202000-00007","article-title":"A new measure of substance abuse treatment: Initial Studies of the Treatment Service Review","volume":"180","author":"McLellan","year":"1992","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2022.108873_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index","volume":"168","author":"McLellan","year":"1980","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2022.108873_bb0100","doi-asserted-by":"crossref","DOI":"10.3928\/00485713-20180417-01","article-title":"The optimal management of opioid use disorder: Leveraging advances in addiction psychopharmacology to enhance treatment outcomes","volume":"48","author":"McGee","year":"2018","journal-title":"Psychiatric Annals"},{"key":"10.1016\/j.jsat.2022.108873_bb0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"Journal of Substance Use Treatment"},{"key":"10.1016\/j.jsat.2022.108873_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jsat.2017.04.016","article-title":"Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone","volume":"85","author":"Nunes","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108873_bb0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ajad.12861","article-title":"Comparison of opioid use disorder among male veterans and non-veterans: Disorder rates, socio-demographics, co-morbidities, and quality of life","volume":"28","author":"Rhee","year":"2019","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2022.108873_bb0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.drugalcdep.2014.09.009","article-title":"Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder","volume":"144","author":"Schumann-Olivier","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2022.108873_bb0130","article-title":"Comparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder","volume":"134","author":"Shaidoo","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108873_bb202209081326359941","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jsat.2017.05.009","article-title":"Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usual","volume":"85","author":"Soares","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108873_bb0135","series-title":"Measuring alcohol consumption: Psychosocial and biological methods","first-page":"41","article-title":"Timeline follow-back: A technique for assessing self-reported ethanol consumption","author":"Sobell","year":"1992"},{"key":"10.1016\/j.jsat.2022.108873_bb0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/add.14737","article-title":"Initiating buprenorphine treatment for opioid use disorder during short-term in-patient \u2018detoxification\u2019: A randomized clinical trial","volume":"115","author":"Stein","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2022.108873_bb0145","article-title":"Medications for opioid use disorder","year":"2021"},{"key":"10.1016\/j.jsat.2022.108873_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.08.003","article-title":"Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health + hospitals buprenorphine ECHO program","volume":"106","author":"Tofighi","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108873_bb0155","first-page":"1444","article-title":"The state of US health, 1990-2016: Burden of diseases, injuries, and risk factors among US states","volume":"14","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2022.108873_bb0160","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/add.14964","article-title":"Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: A cohort analysis","volume":"115","author":"Walley","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2022.108873_bb0165","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.addbeh.2012.04.011","article-title":"Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth","volume":"37","author":"Warden","year":"2012","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2022.108873_bb0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/ajad.12527","article-title":"Long-term follow-up study of community-based patients receiving SR-NTX for opioid use disorders","volume":"26","author":"Williams","year":"2017","journal-title":"The American Journal on Addictions"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222001556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222001556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:58:36Z","timestamp":1760039916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547222001556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"alternative-id":["S0740547222001556"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108873","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid relapse and MOUD outcomes following civil commitment for opioid use","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108873"}}